首页>
美国卫生研究院文献>BMJ Open
>Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre open-label phase II INTERACT-II trial
【2h】
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre open-label phase II INTERACT-II trial